The FDA has accepted the resubmission of a BLA for odronextamab for the treatment of patients with relapsed/refractory ...
Zevra has sold its US Food and Drug Administration (FDA) priority review voucher (PRV) for $150m to an undisclosed party.
Brian Tyree Henry delivers an excellent performance in Dope Thief, a Philly-based crime show. Stealing drugs and money does ...
FDA application for its NorthStar mapping system, which is slated for submission next. The company is following a 510(k) ...
Pearl, the global leader in dental AI solutions, today announced Claimcheck, an AI-powered tool for optimizing the insurance claim submission process to reduce costly errors and accelerate revenue for ...
The FDA has started a priority review of Insmed's brensocatib ... the walls of the airways become thickened and damaged as a result of a cycle of inflammation and infections.
Congress did not reauthorize the rare pediatric disease priority review program at the end of 2024. Advocates say the ripple ...
The Senate is finding itself in a familiar position, working to avoid a partial government shutdown with just hours to spare ...
Prolific offenders fuelled by drugs will be spared jail under plans for Texas-style “problem solving” courts to treat the causes of their crimes ...
Zevra has sold its US Food and Drug Administration (FDA) priority review voucher (PRV ... launches of Miplyffa and the company’s urea cycle disorder drug Olpruva, which it inherited as part ...
Focused on the uneasy reunion between two estranged cousins who team up to beat the cycle of drug abuse and debt that’s been dragging their family down for decades, this is ambitious ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results